Medical Care
Global Antiviral Therapeutics Market Research Report 2025
- Jul 08, 25
- ID: 347743
- Pages: 90
- Figures: 90
- Views: 38
The global market for Antiviral Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Therapeutics.
The Antiviral Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Bristol-Myers Squibb Company
Johnson & Johnson
Sanofi
Segment by Type
Herpes Antiviral Drugs
Hepatitis Antiviral Drugs
HIV Antiviral Drugs
Influenza Antiviral Drugs
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Antiviral Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antiviral Therapeutics.
The Antiviral Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Antiviral Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antiviral Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
AbbVie Inc.
GSK
Boehringer Ingelheim
Merck
Novartis
Beximco Pharmaceuticals
Pfizer
Roche
Bristol-Myers Squibb Company
Johnson & Johnson
Sanofi
Segment by Type
Herpes Antiviral Drugs
Hepatitis Antiviral Drugs
HIV Antiviral Drugs
Influenza Antiviral Drugs
Others
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
Pharmacies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antiviral Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Herpes Antiviral Drugs
1.2.3 Hepatitis Antiviral Drugs
1.2.4 HIV Antiviral Drugs
1.2.5 Influenza Antiviral Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Antiviral Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Therapeutics Market Perspective (2020-2031)
2.2 Global Antiviral Therapeutics Growth Trends by Region
2.2.1 Global Antiviral Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiviral Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Antiviral Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Antiviral Therapeutics Market Dynamics
2.3.1 Antiviral Therapeutics Industry Trends
2.3.2 Antiviral Therapeutics Market Drivers
2.3.3 Antiviral Therapeutics Market Challenges
2.3.4 Antiviral Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Therapeutics Players by Revenue
3.1.1 Global Top Antiviral Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Antiviral Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Antiviral Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiviral Therapeutics Revenue
3.4 Global Antiviral Therapeutics Market Concentration Ratio
3.4.1 Global Antiviral Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Therapeutics Revenue in 2024
3.5 Global Key Players of Antiviral Therapeutics Head office and Area Served
3.6 Global Key Players of Antiviral Therapeutics, Product and Application
3.7 Global Key Players of Antiviral Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Therapeutics Breakdown Data by Type
4.1 Global Antiviral Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Antiviral Therapeutics Forecasted Market Size by Type (2026-2031)
5 Antiviral Therapeutics Breakdown Data by Application
5.1 Global Antiviral Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Antiviral Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiviral Therapeutics Market Size (2020-2031)
6.2 North America Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiviral Therapeutics Market Size by Country (2020-2025)
6.4 North America Antiviral Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Therapeutics Market Size (2020-2031)
7.2 Europe Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiviral Therapeutics Market Size by Country (2020-2025)
7.4 Europe Antiviral Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Antiviral Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiviral Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiviral Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Therapeutics Market Size (2020-2031)
9.2 Latin America Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiviral Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Antiviral Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiviral Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiviral Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Antiviral Therapeutics Introduction
11.1.4 AbbVie Inc. Revenue in Antiviral Therapeutics Business (2020-2025)
11.1.5 AbbVie Inc. Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Antiviral Therapeutics Introduction
11.2.4 GSK Revenue in Antiviral Therapeutics Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Antiviral Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Therapeutics Introduction
11.4.4 Merck Revenue in Antiviral Therapeutics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antiviral Therapeutics Introduction
11.5.4 Novartis Revenue in Antiviral Therapeutics Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Beximco Pharmaceuticals
11.6.1 Beximco Pharmaceuticals Company Details
11.6.2 Beximco Pharmaceuticals Business Overview
11.6.3 Beximco Pharmaceuticals Antiviral Therapeutics Introduction
11.6.4 Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2020-2025)
11.6.5 Beximco Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antiviral Therapeutics Introduction
11.7.4 Pfizer Revenue in Antiviral Therapeutics Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Antiviral Therapeutics Introduction
11.8.4 Roche Revenue in Antiviral Therapeutics Business (2020-2025)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Antiviral Therapeutics Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2020-2025)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Antiviral Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Antiviral Therapeutics Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Antiviral Therapeutics Introduction
11.11.4 Sanofi Revenue in Antiviral Therapeutics Business (2020-2025)
11.11.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiviral Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Herpes Antiviral Drugs
1.2.3 Hepatitis Antiviral Drugs
1.2.4 HIV Antiviral Drugs
1.2.5 Influenza Antiviral Drugs
1.2.6 Others
1.3 Market by Application
1.3.1 Global Antiviral Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.3.5 Pharmacies
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antiviral Therapeutics Market Perspective (2020-2031)
2.2 Global Antiviral Therapeutics Growth Trends by Region
2.2.1 Global Antiviral Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Antiviral Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 Antiviral Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 Antiviral Therapeutics Market Dynamics
2.3.1 Antiviral Therapeutics Industry Trends
2.3.2 Antiviral Therapeutics Market Drivers
2.3.3 Antiviral Therapeutics Market Challenges
2.3.4 Antiviral Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antiviral Therapeutics Players by Revenue
3.1.1 Global Top Antiviral Therapeutics Players by Revenue (2020-2025)
3.1.2 Global Antiviral Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global Antiviral Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Antiviral Therapeutics Revenue
3.4 Global Antiviral Therapeutics Market Concentration Ratio
3.4.1 Global Antiviral Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiviral Therapeutics Revenue in 2024
3.5 Global Key Players of Antiviral Therapeutics Head office and Area Served
3.6 Global Key Players of Antiviral Therapeutics, Product and Application
3.7 Global Key Players of Antiviral Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Antiviral Therapeutics Breakdown Data by Type
4.1 Global Antiviral Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global Antiviral Therapeutics Forecasted Market Size by Type (2026-2031)
5 Antiviral Therapeutics Breakdown Data by Application
5.1 Global Antiviral Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global Antiviral Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Antiviral Therapeutics Market Size (2020-2031)
6.2 North America Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Antiviral Therapeutics Market Size by Country (2020-2025)
6.4 North America Antiviral Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antiviral Therapeutics Market Size (2020-2031)
7.2 Europe Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Antiviral Therapeutics Market Size by Country (2020-2025)
7.4 Europe Antiviral Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antiviral Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific Antiviral Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Antiviral Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific Antiviral Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antiviral Therapeutics Market Size (2020-2031)
9.2 Latin America Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Antiviral Therapeutics Market Size by Country (2020-2025)
9.4 Latin America Antiviral Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antiviral Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa Antiviral Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Antiviral Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa Antiviral Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie Inc.
11.1.1 AbbVie Inc. Company Details
11.1.2 AbbVie Inc. Business Overview
11.1.3 AbbVie Inc. Antiviral Therapeutics Introduction
11.1.4 AbbVie Inc. Revenue in Antiviral Therapeutics Business (2020-2025)
11.1.5 AbbVie Inc. Recent Development
11.2 GSK
11.2.1 GSK Company Details
11.2.2 GSK Business Overview
11.2.3 GSK Antiviral Therapeutics Introduction
11.2.4 GSK Revenue in Antiviral Therapeutics Business (2020-2025)
11.2.5 GSK Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Details
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Antiviral Therapeutics Introduction
11.3.4 Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2020-2025)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Antiviral Therapeutics Introduction
11.4.4 Merck Revenue in Antiviral Therapeutics Business (2020-2025)
11.4.5 Merck Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Antiviral Therapeutics Introduction
11.5.4 Novartis Revenue in Antiviral Therapeutics Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Beximco Pharmaceuticals
11.6.1 Beximco Pharmaceuticals Company Details
11.6.2 Beximco Pharmaceuticals Business Overview
11.6.3 Beximco Pharmaceuticals Antiviral Therapeutics Introduction
11.6.4 Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2020-2025)
11.6.5 Beximco Pharmaceuticals Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Antiviral Therapeutics Introduction
11.7.4 Pfizer Revenue in Antiviral Therapeutics Business (2020-2025)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Antiviral Therapeutics Introduction
11.8.4 Roche Revenue in Antiviral Therapeutics Business (2020-2025)
11.8.5 Roche Recent Development
11.9 Bristol-Myers Squibb Company
11.9.1 Bristol-Myers Squibb Company Company Details
11.9.2 Bristol-Myers Squibb Company Business Overview
11.9.3 Bristol-Myers Squibb Company Antiviral Therapeutics Introduction
11.9.4 Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2020-2025)
11.9.5 Bristol-Myers Squibb Company Recent Development
11.10 Johnson & Johnson
11.10.1 Johnson & Johnson Company Details
11.10.2 Johnson & Johnson Business Overview
11.10.3 Johnson & Johnson Antiviral Therapeutics Introduction
11.10.4 Johnson & Johnson Revenue in Antiviral Therapeutics Business (2020-2025)
11.10.5 Johnson & Johnson Recent Development
11.11 Sanofi
11.11.1 Sanofi Company Details
11.11.2 Sanofi Business Overview
11.11.3 Sanofi Antiviral Therapeutics Introduction
11.11.4 Sanofi Revenue in Antiviral Therapeutics Business (2020-2025)
11.11.5 Sanofi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Antiviral Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Herpes Antiviral Drugs
Table 3. Key Players of Hepatitis Antiviral Drugs
Table 4. Key Players of HIV Antiviral Drugs
Table 5. Key Players of Influenza Antiviral Drugs
Table 6. Key Players of Others
Table 7. Global Antiviral Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antiviral Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Antiviral Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Antiviral Therapeutics Market Share by Region (2020-2025)
Table 11. Global Antiviral Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Antiviral Therapeutics Market Share by Region (2026-2031)
Table 13. Antiviral Therapeutics Market Trends
Table 14. Antiviral Therapeutics Market Drivers
Table 15. Antiviral Therapeutics Market Challenges
Table 16. Antiviral Therapeutics Market Restraints
Table 17. Global Antiviral Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Antiviral Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapeutics as of 2024)
Table 20. Ranking of Global Top Antiviral Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Antiviral Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Antiviral Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Antiviral Therapeutics, Product and Application
Table 24. Global Key Players of Antiviral Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiviral Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Antiviral Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Antiviral Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Antiviral Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Antiviral Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Antiviral Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Antiviral Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Antiviral Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Antiviral Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Antiviral Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Antiviral Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. AbbVie Inc. Company Details
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Antiviral Therapeutics Product
Table 52. AbbVie Inc. Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 53. AbbVie Inc. Recent Development
Table 54. GSK Company Details
Table 55. GSK Business Overview
Table 56. GSK Antiviral Therapeutics Product
Table 57. GSK Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Boehringer Ingelheim Company Details
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Antiviral Therapeutics Product
Table 62. Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Antiviral Therapeutics Product
Table 67. Merck Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Antiviral Therapeutics Product
Table 72. Novartis Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Beximco Pharmaceuticals Company Details
Table 75. Beximco Pharmaceuticals Business Overview
Table 76. Beximco Pharmaceuticals Antiviral Therapeutics Product
Table 77. Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Beximco Pharmaceuticals Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Antiviral Therapeutics Product
Table 82. Pfizer Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Antiviral Therapeutics Product
Table 87. Roche Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Bristol-Myers Squibb Company Company Details
Table 90. Bristol-Myers Squibb Company Business Overview
Table 91. Bristol-Myers Squibb Company Antiviral Therapeutics Product
Table 92. Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Bristol-Myers Squibb Company Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Antiviral Therapeutics Product
Table 97. Johnson & Johnson Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Antiviral Therapeutics Product
Table 102. Sanofi Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Antiviral Therapeutics Picture
Figure 2. Global Antiviral Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiviral Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Herpes Antiviral Drugs Features
Figure 5. Hepatitis Antiviral Drugs Features
Figure 6. HIV Antiviral Drugs Features
Figure 7. Influenza Antiviral Drugs Features
Figure 8. Others Features
Figure 9. Global Antiviral Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Antiviral Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Pharmacies Case Studies
Figure 15. Others Case Studies
Figure 16. Antiviral Therapeutics Report Years Considered
Figure 17. Global Antiviral Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Antiviral Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Antiviral Therapeutics Market Share by Region: 2024 VS 2031
Figure 20. Global Antiviral Therapeutics Market Share by Players in 2024
Figure 21. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapeutics as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Antiviral Therapeutics Revenue in 2024
Figure 23. North America Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 25. United States Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 29. Germany Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Antiviral Therapeutics Market Share by Region (2020-2031)
Figure 37. China Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 45. Mexico Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 49. Turkey Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. AbbVie Inc. Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 53. GSK Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 57. Beximco Pharmaceuticals Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 61. Johnson & Johnson Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 62. Sanofi Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Table 1. Global Antiviral Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Herpes Antiviral Drugs
Table 3. Key Players of Hepatitis Antiviral Drugs
Table 4. Key Players of HIV Antiviral Drugs
Table 5. Key Players of Influenza Antiviral Drugs
Table 6. Key Players of Others
Table 7. Global Antiviral Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Antiviral Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Antiviral Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Antiviral Therapeutics Market Share by Region (2020-2025)
Table 11. Global Antiviral Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Antiviral Therapeutics Market Share by Region (2026-2031)
Table 13. Antiviral Therapeutics Market Trends
Table 14. Antiviral Therapeutics Market Drivers
Table 15. Antiviral Therapeutics Market Challenges
Table 16. Antiviral Therapeutics Market Restraints
Table 17. Global Antiviral Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Antiviral Therapeutics Market Share by Players (2020-2025)
Table 19. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapeutics as of 2024)
Table 20. Ranking of Global Top Antiviral Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Antiviral Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Antiviral Therapeutics, Headquarters and Area Served
Table 23. Global Key Players of Antiviral Therapeutics, Product and Application
Table 24. Global Key Players of Antiviral Therapeutics, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Antiviral Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Antiviral Therapeutics Revenue Market Share by Type (2020-2025)
Table 28. Global Antiviral Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Antiviral Therapeutics Revenue Market Share by Type (2026-2031)
Table 30. Global Antiviral Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Antiviral Therapeutics Revenue Market Share by Application (2020-2025)
Table 32. Global Antiviral Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Antiviral Therapeutics Revenue Market Share by Application (2026-2031)
Table 34. North America Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Antiviral Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Antiviral Therapeutics Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Antiviral Therapeutics Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Antiviral Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Antiviral Therapeutics Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Antiviral Therapeutics Market Size by Country (2026-2031) & (US$ Million)
Table 49. AbbVie Inc. Company Details
Table 50. AbbVie Inc. Business Overview
Table 51. AbbVie Inc. Antiviral Therapeutics Product
Table 52. AbbVie Inc. Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 53. AbbVie Inc. Recent Development
Table 54. GSK Company Details
Table 55. GSK Business Overview
Table 56. GSK Antiviral Therapeutics Product
Table 57. GSK Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 58. GSK Recent Development
Table 59. Boehringer Ingelheim Company Details
Table 60. Boehringer Ingelheim Business Overview
Table 61. Boehringer Ingelheim Antiviral Therapeutics Product
Table 62. Boehringer Ingelheim Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 63. Boehringer Ingelheim Recent Development
Table 64. Merck Company Details
Table 65. Merck Business Overview
Table 66. Merck Antiviral Therapeutics Product
Table 67. Merck Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 68. Merck Recent Development
Table 69. Novartis Company Details
Table 70. Novartis Business Overview
Table 71. Novartis Antiviral Therapeutics Product
Table 72. Novartis Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 73. Novartis Recent Development
Table 74. Beximco Pharmaceuticals Company Details
Table 75. Beximco Pharmaceuticals Business Overview
Table 76. Beximco Pharmaceuticals Antiviral Therapeutics Product
Table 77. Beximco Pharmaceuticals Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 78. Beximco Pharmaceuticals Recent Development
Table 79. Pfizer Company Details
Table 80. Pfizer Business Overview
Table 81. Pfizer Antiviral Therapeutics Product
Table 82. Pfizer Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 83. Pfizer Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Antiviral Therapeutics Product
Table 87. Roche Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 88. Roche Recent Development
Table 89. Bristol-Myers Squibb Company Company Details
Table 90. Bristol-Myers Squibb Company Business Overview
Table 91. Bristol-Myers Squibb Company Antiviral Therapeutics Product
Table 92. Bristol-Myers Squibb Company Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 93. Bristol-Myers Squibb Company Recent Development
Table 94. Johnson & Johnson Company Details
Table 95. Johnson & Johnson Business Overview
Table 96. Johnson & Johnson Antiviral Therapeutics Product
Table 97. Johnson & Johnson Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 98. Johnson & Johnson Recent Development
Table 99. Sanofi Company Details
Table 100. Sanofi Business Overview
Table 101. Sanofi Antiviral Therapeutics Product
Table 102. Sanofi Revenue in Antiviral Therapeutics Business (2020-2025) & (US$ Million)
Table 103. Sanofi Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
Table 107. Authors List of This Report
List of Figures
Figure 1. Antiviral Therapeutics Picture
Figure 2. Global Antiviral Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Antiviral Therapeutics Market Share by Type: 2024 VS 2031
Figure 4. Herpes Antiviral Drugs Features
Figure 5. Hepatitis Antiviral Drugs Features
Figure 6. HIV Antiviral Drugs Features
Figure 7. Influenza Antiviral Drugs Features
Figure 8. Others Features
Figure 9. Global Antiviral Therapeutics Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Antiviral Therapeutics Market Share by Application: 2024 VS 2031
Figure 11. Hospitals Case Studies
Figure 12. Clinics Case Studies
Figure 13. Ambulatory Surgical Centers Case Studies
Figure 14. Pharmacies Case Studies
Figure 15. Others Case Studies
Figure 16. Antiviral Therapeutics Report Years Considered
Figure 17. Global Antiviral Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Antiviral Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Antiviral Therapeutics Market Share by Region: 2024 VS 2031
Figure 20. Global Antiviral Therapeutics Market Share by Players in 2024
Figure 21. Global Top Antiviral Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antiviral Therapeutics as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Antiviral Therapeutics Revenue in 2024
Figure 23. North America Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 25. United States Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 29. Germany Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Antiviral Therapeutics Market Share by Region (2020-2031)
Figure 37. China Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 45. Mexico Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Antiviral Therapeutics Market Share by Country (2020-2031)
Figure 49. Turkey Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Antiviral Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. AbbVie Inc. Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 53. GSK Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 54. Boehringer Ingelheim Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 55. Merck Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 56. Novartis Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 57. Beximco Pharmaceuticals Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 58. Pfizer Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 59. Roche Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 60. Bristol-Myers Squibb Company Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 61. Johnson & Johnson Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 62. Sanofi Revenue Growth Rate in Antiviral Therapeutics Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Smart Grid Digital Substation Market Research Report 2026
Mar 17, 26
Global Photovoltaic Molded Case Circuit Breaker Market Research Report 2026
Mar 17, 26
Global Roll-Roll Automobile Business Market Research Report 2026
Mar 17, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232